BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35294799)

  • 21. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls.
    Søfteland JM; Gisslén M; Liljeqvist JÅ; Friman V; de Coursey E; Karason K; Ekelund J; Felldin M; Magnusson J; Baid-Agrawal S; Wallquist C; Schult A; Jacobsson H; Bergdahl A; Bemark M; Andersson LM; Holm Gunnarsson I; Stenström J; Leach S
    Am J Transplant; 2022 Apr; 22(4):1245-1252. PubMed ID: 34860447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
    Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
    Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of COVID-19 on pediatric and adult solid organ transplant recipients and the emergence of telehealth.
    Raina R; Shah R; Marks SD; Johnson JN; Nied M; Bhatt GC; Bonham CA; Datla N; Sethi SK; Bartosh SM
    Pediatr Transplant; 2023 Jun; 27(4):e14490. PubMed ID: 36879358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARDS in solid organ transplant recipients hospitalized for COVID-19 based on the 2023 new definition.
    Tang J; Zhou Y; Gong L; Deng J; Yuan Y; Zhong Y; Li J; Wang G
    Heart Lung; 2024; 66():103-107. PubMed ID: 38604053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pragmatic outreach pilot to understand and overcome barriers to COVID-19 vaccination in abdominal organ transplant.
    Serper M; Liu CH; Blumberg EA; Burdzy AE; Veasey S; Halpern S; Lander E; Sigafus MR; Bloom RD; Dunn TB; Abt PL; Reddy KR; Mehta SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13722. PubMed ID: 34496115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
    Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
    Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
    Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
    Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic.
    Nimmo A; Gardiner D; Ushiro-Lumb I; Ravanan R; Forsythe JLR
    Transplantation; 2022 Jul; 106(7):1312-1329. PubMed ID: 35404911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
    D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
    J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study.
    Chaudhry ZS; Williams JD; Vahia A; Fadel R; Parraga Acosta T; Prashar R; Shrivastava P; Khoury N; Pinto Corrales J; Williams C; Nagai S; Abouljoud M; Samaniego-Picota M; Abreu-Lanfranco O; Del Busto R; Ramesh MS; Patel A; Alangaden GJ
    Am J Transplant; 2020 Nov; 20(11):3051-3060. PubMed ID: 32654332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies.
    Tang Y; Li Y; Song T
    Front Immunol; 2023; 14():1150341. PubMed ID: 37081880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
    Mrzljak A; Jureković Ž; Pavičić-Šarić J; Stevanović V; Tabain I; Hruškar Ž; Mikulić D; Barbić L; Vilibić-Čavlek T
    Biochem Med (Zagreb); 2021 Oct; 31(3):030901. PubMed ID: 34658649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
    Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
    JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, Risk Factors, and Outcomes of COVID-19 Infection in a Large Cohort of Solid Organ Transplant Recipients.
    Sahota A; Tien A; Yao J; Dong E; Herald J; Javaherifar S; Neyer J; Hwang J; Lee R; Fong TL
    Transplantation; 2022 Dec; 106(12):2426-2434. PubMed ID: 36436102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort.
    Permpalung N; Chiang TP; Manothummetha K; Ostrander D; Datta K; Segev DL; Durand CM; Mostafa HH; Zhang SX; Massie AB; Marr KA; Avery RK
    Transplantation; 2024 Feb; ():. PubMed ID: 38419156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population.
    Vinson AJ; Anzalone A; Schissel M; Dai R; French ET; Olex AL; Mannon RB;
    Am J Transplant; 2023 Jul; 23(7):1035-1047. PubMed ID: 37105315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge.
    Radcliffe C; Palacios CF; Azar MM; Cohen E; Malinis M
    Am J Transplant; 2022 Oct; 22(10):2458-2463. PubMed ID: 35583664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.
    Hamm SR; Rezahosseini O; Møller DL; Loft JA; Poulsen JR; Knudsen JD; Pedersen MS; Schønning K; Harboe ZB; Rasmussen A; Sørensen SS; Nielsen SD
    Am J Transplant; 2022 Nov; 22(11):2637-2650. PubMed ID: 35801693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study.
    Lim JH; Nam E; Seo YJ; Jung HY; Choi JY; Cho JH; Park SH; Kim CD; Kim YL; Bae S; Hwang S; Kim Y; Chang HH; Kim SW; Jung J; Kwon KT
    Infect Chemother; 2024 May; ():. PubMed ID: 38859715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
    Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
    Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.